Shaker Benjamin 4
4 · agilon health, inc. · Filed Sep 14, 2023
Insider Transaction Report
Form 4
Shaker Benjamin
Chief Markets Officer
Transactions
- Sale
Common Stock
2023-09-13$18.00/sh−18,750$337,455→ 79,543 total - Exercise/Conversion
Common Stock
2023-09-12$3.79/sh+18,750$71,063→ 98,293 total - Sale
Common Stock
2023-09-12$18.05/sh−18,750$338,481→ 79,543 total - Exercise/Conversion
Common Stock
2023-09-13$3.79/sh+18,750$71,063→ 98,293 total - Exercise/Conversion
Options (Right to buy)
2023-09-12−18,750→ 320,601 totalExercise: $3.79Exp: 2029-02-09→ Common Stock (18,750 underlying) - Exercise/Conversion
Options (Right to buy)
2023-09-13−18,750→ 301,851 totalExercise: $3.79Exp: 2029-02-09→ Common Stock (18,750 underlying)
Footnotes (5)
- [F1]Includes restricted stock units.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective September 15, 2022.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.76 to $18.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.67 to $18.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F5]These options were granted on February 9, 2019, and became fully vested as of February 9, 2023.